INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 179 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,999 | -78.0% | 1,672 | -86.8% | 0.00% | -80.0% |
| Q2 2023 | $140,595 | +104821.6% | 12,712 | +27.5% | 0.01% | +25.0% |
| Q1 2023 | $134 | +9.8% | 9,973 | +1.0% | 0.00% | -20.0% |
| Q4 2022 | $122 | -100.0% | 9,876 | -73.6% | 0.01% | -37.5% |
| Q3 2022 | $521,000 | +349.1% | 37,372 | +343.9% | 0.01% | +166.7% |
| Q2 2022 | $116,000 | +81.2% | 8,419 | +112.5% | 0.00% | +200.0% |
| Q1 2022 | $64,000 | -48.0% | 3,962 | -47.4% | 0.00% | -50.0% |
| Q4 2021 | $123,000 | -48.5% | 7,538 | -53.1% | 0.00% | -66.7% |
| Q3 2021 | $239,000 | +342.6% | 16,073 | +492.7% | 0.01% | +500.0% |
| Q2 2021 | $54,000 | +3.8% | 2,712 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $52,000 | -78.5% | 2,251 | -77.1% | 0.00% | -85.7% |
| Q4 2020 | $242,000 | +188.1% | 9,812 | +386.2% | 0.01% | +600.0% |
| Q3 2020 | $84,000 | -55.6% | 2,018 | -49.0% | 0.00% | -87.5% |
| Q2 2020 | $189,000 | +425.0% | 3,956 | +619.3% | 0.01% | +300.0% |
| Q3 2019 | $36,000 | +100.0% | 550 | +239.5% | 0.00% | +100.0% |
| Q1 2019 | $18,000 | -30.8% | 162 | -37.5% | 0.00% | -50.0% |
| Q4 2018 | $26,000 | +100.0% | 259 | +161.6% | 0.00% | +100.0% |
| Q3 2018 | $13,000 | -89.0% | 99 | -94.8% | 0.00% | -90.0% |
| Q1 2018 | $118,000 | +93.4% | 1,916 | +84.9% | 0.01% | +25.0% |
| Q4 2017 | $61,000 | +35.6% | 1,036 | +33.2% | 0.01% | +100.0% |
| Q3 2017 | $45,000 | +200.0% | 778 | +507.8% | 0.00% | +100.0% |
| Q2 2017 | $15,000 | +200.0% | 128 | +204.8% | 0.00% | – |
| Q1 2017 | $5,000 | -78.3% | 42 | -80.1% | 0.00% | -100.0% |
| Q4 2016 | $23,000 | +155.6% | 211 | +276.8% | 0.00% | +100.0% |
| Q3 2016 | $9,000 | -55.0% | 56 | -60.3% | 0.00% | -50.0% |
| Q2 2016 | $20,000 | -81.7% | 141 | -83.3% | 0.00% | -87.5% |
| Q1 2016 | $109,000 | +738.5% | 846 | +1526.9% | 0.02% | +1500.0% |
| Q2 2015 | $13,000 | +550.0% | 52 | +642.9% | 0.00% | – |
| Q3 2014 | $2,000 | -97.4% | 7 | -99.4% | 0.00% | -100.0% |
| Q4 2013 | $78,000 | +212.0% | 1,146 | +217.5% | 0.01% | +333.3% |
| Q3 2013 | $25,000 | +8.7% | 361 | -30.8% | 0.00% | +50.0% |
| Q2 2013 | $23,000 | – | 522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |